Jinchun Xing

机构：First Affiliated Hospital of Xiamen University

发表论文 14 篇 · 总被引 71 次 · h-index 3

代表论文

• miR-29b negatively regulates MMP2 to impact gastric cancer development by suppress gastric cancer cell migration and tumor growth (2018 · Journal of Cancer · 被引 39)
• CACA guidelines for holistic integrative management of prostate cancer (2024 · Holistic Integrative Oncology · 被引 22)
• The Status and Characteristics of Urinary Stone Composition in China (2018 · SSRN Electronic Journal · 被引 5)
• Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum (2021 · Theranostics · 被引 2)
• A phase 1b/2 study to evaluate the safety and efficacy of igermetostat (XNW5004) in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer. (2026 · Journal of Clinical Oncology · 被引 1)
• A prospective, randomized, cross-over trial to assess patient preference for goserelin microsphere versus goserelin implant in prostate cancer: Interim results of the GOMIMP study. (2026 · Journal of Clinical Oncology · 被引 1)